Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology

Lipoprotein(a): An underestimated inflammatory mastermind

(2022) Kim E. Dzobo et al.   ATHEROSCLEROSIS

Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective

(2022) Benoit J. Arsenault et al.   ATHEROSCLEROSIS

Apolipoprotein B is an insufficient explanation for the risk of coronary disease associated with lipoprotein(a)

(2021) Mark Trinder et al.   CARDIOVASCULAR RESEARCH

Accumulation of Plasma-Derived Lipids in the Lipid Core and Necrotic Core of Human Atheroma: Imaging Mass Spectrometry and Histopathological Analyses

(2021) Kazunori Nakagawa et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization

(2021) Francesca Fasolo et al.   CIRCULATION

Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation

(2020) Johan G. Schnitzler et al.   CIRCULATION RESEARCH

Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease

(2019) Michael B. Boffa et al.   Nature Reviews Cardiology

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis

(2019) Kang H. Zheng et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The role of (modified) lipoproteins in vascular function: a duet between monocytes and the endothelium

(2018) Johan G. Schnitzler et al.   CURRENT MEDICINAL CHEMISTRY

Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice

(2018) Xuchu Que et al.   NATURE

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective

(2016) Fleur M. van der Valk et al.   CIRCULATION

Lysophospholipids and their G protein-coupled receptors in atherosclerosis

(2016) Rong-Shan Li   Frontiers in Bioscience-Landmark

Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease

(2016) M. J. Nsaibia et al.   JOURNAL OF INTERNAL MEDICINE

Heritability of Biomarkers of Oxidized LipoproteinsSignificance

(2015) Fangwen Rao et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic ValveCLINICAL PERSPECTIVE

(2015) Rihab Bouchareb et al.   CIRCULATION

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)

(2015) Corey A. Scipione et al.   JOURNAL OF LIPID RESEARCH

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

(2015) Romain Capoulade et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Phosphoproteomic Analysis of Platelets Activated by Pro-Thrombotic Oxidized Phospholipids and Thrombin

(2014) Alejandro Zimman et al.   PLoS One

Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)

(2013) Gregor Leibundgut et al.   JOURNAL OF LIPID RESEARCH

Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease

(2013) Ablajan Mahmut et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions

(2012) Rogier A. van Dijk et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)

(2012) Taewoo Cho et al.   MOLECULAR BIOLOGY OF THE CELL

Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events

(2011) Adam Taleb et al.   Biomarkers in Medicine

Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium

(2011) Zhe Zhou et al.   Cell Metabolism

Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress

(2010) Tracie A. Seimon et al.   Cell Metabolism

Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study

(2010) Kåre Berg et al.   CLINICAL GENETICS

Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events

(2010) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles

(2009) Kiyohito Arai et al.   ATHEROSCLEROSIS

Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors

(2009) Sotirios Tsimikas et al.   CIRCULATION

The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin

(2008) Celina Edelstein et al.   FASEB JOURNAL

Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway

(2008) Taewoo Cho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The role of oxidized phospholipids in atherosclerosis: Fig. 1.

(2008) Judith A. Berliner et al.   JOURNAL OF LIPID RESEARCH

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

(2008) Claes Bergmark et al.   JOURNAL OF LIPID RESEARCH